News 07.04.2026 ETH Professor Emeritus Ruedi Aebersold, together with John Yates from the Scripps Research Institute in La Jolla, USA, and Matthias Mann from the Max Planck Institute in Martinsried, Germany, has been honoured with the prestigious Canada Gairdner International Award. The three scientists founded and shaped modern proteomics research. See full article:...
News 01.04.2026 Schlieren, Zurich — Surgical Fusion Technologies has received a 1.2 million Swiss franc grant from Innosuisse to further develop its surgical method for sports medicine. The medtech company uses an ultrasound generator to create bioresorbable anchors that connect soft tissue to bone. The Swiss innovation agency Innosuisse is supporting Surgical Fusion...
News 31.03.2026 A new peer-reviewed publication reports 1-year results from a prospective, randomized, intra-patient controlled, multicenter phase II clinical trial evaluating denovoSkin™ in reconstructive surgery in patients of all ages. The study evaluated denovoSkin™ against autologous split-thickness skin grafts (STSG) in 23 patients with full-thickness skin defects requiring planned elective reconstruction. According to...
News 23.03.2026 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 23, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today published the invitation to the Annual General Meeting 2026 and...
News 20.03.2026 CUTISS has been granted a new patent in the United States for a disposable system and method used in the preparation of compressed hydrogels for tissue engineering applications. The patent (U.S. Patent No. 12,564,662 B2), titled “Disposable system and method for preparing a compressed hydrogel”, protects a fully disposable system for...